Literature DB >> 7912453

Analysis of restriction fragment length polymorphism for the HLA-DR gene in Japanese patients with sarcoidosis.

H Kunikane1, S Abe, E Yamaguchi, J M Aparicio, A Wakisaka, T Yoshiki, Y Kawakami.   

Abstract

BACKGROUND: It is commonly assumed that some immunological disorder may play a part in the pathogenesis of sarcoidosis. Previous studies by several groups have shown a significant association with HLA-DR antigens in patients with sarcoidosis. In this study, restriction fragment length polymorphism (RFLP) analysis of the HLA-DR gene was designed to confirm the association at the gene level and to look for a gene rearrangement which may influence susceptibility to sarcoidosis.
METHODS: Thirty two unrelated Japanese patients with sarcoidosis were tested for HLA antigens and subjected to RFLP analysis after digestion with Eco RI, Pst I, Bam HI, Pvu II, and Hind III by using an HLA-DR beta cDNA probe. A group of 47 unrelated healthy Japanese subjects served as controls. Frequencies of each restriction fragment were compared between the patients and the control subjects. Correlation between fragment frequencies and clinical features were also analysed.
RESULTS: No restriction fragments of HLA-DR beta gene were found specific to the patients with sarcoidosis. The RFLP analysis could detect polymorphism of HLA-DR beta genes that was not distinguishable by conventional serological methods. Several restriction fragments of the DR beta gene were seen only in DRw52 positive individuals, and showed higher frequencies in the patients than in control subjects. The patients with these DNA fragments were likely to have limited stage disease with no ophthalmic involvement.
CONCLUSIONS: An association between HLA and sarcoidosis was noted at the DNA level, although no restriction fragments were specific for this disease. RFLP analysis of the HLA gene is a more useful method than the usual HLA typing, and should be the first step in identifying the gene sequence which is connected with susceptibility to sarcoidosis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7912453      PMCID: PMC474947          DOI: 10.1136/thx.49.6.573

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  14 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  Mapping of the class II region of the human major histocompatibility complex by pulsed-field gel electrophoresis.

Authors:  D A Hardy; J I Bell; E O Long; T Lindsten; H O McDevitt
Journal:  Nature       Date:  1986 Oct 2-8       Impact factor: 49.962

3.  Monoclonal antibody definition of multiple polymorphic epitopes on human leukocyte antigen-DRw52.

Authors:  S V Fuggle; C Carter; F Watts; J Kirkley; P J Morris
Journal:  Hum Immunol       Date:  1987-11       Impact factor: 2.850

4.  HL-A antigens of patients with sarcoidosis.

Authors:  F Kueppers; C Mueller-Eckhardt; D Heinrich; B Schwab; D Brackertz
Journal:  Tissue Antigens       Date:  1974

Review 5.  Molecular organization of the class I genes of human major histocompatibility complex.

Authors:  R Srivastava; B W Duceman; P A Biro; A K Sood; S M Weissman
Journal:  Immunol Rev       Date:  1985-07       Impact factor: 12.988

Review 6.  The class II molecules of the human and murine major histocompatibility complex.

Authors:  J F Kaufman; C Auffray; A J Korman; D A Shackelford; J Strominger
Journal:  Cell       Date:  1984-01       Impact factor: 41.582

7.  Immunogenetics of response to a purified antigen from group A streptococci. II. Linkage of response to HLA.

Authors:  L J Greenberg; R L Chopyk; P W Bradley; J M Lalouel
Journal:  Immunogenetics       Date:  1980       Impact factor: 2.846

8.  HLA-B8 in sarcoidosis.

Authors:  S A Olenchock; E R Heise; J J Marx; M S Mentnech; J C Mull; D E Spurgeon; J S Hancock; J A Elliott; D J Pearson; C D Price; P C Major
Journal:  Ann Allergy       Date:  1981-09

Review 9.  Structure and polymorphism of murine and human class II major histocompatibility antigens.

Authors:  J I Bell; D W Denny; H O McDevitt
Journal:  Immunol Rev       Date:  1985-07       Impact factor: 12.988

10.  Complete sequence of an HLA-dR beta chain deduced from a cDNA clone and identification of multiple non-allelic DR beta chain genes.

Authors:  E O Long; C T Wake; J Gorski; B Mach
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

View more
  2 in total

1.  Infliximab therapy for hepatic and intestinal sarcoidosis.

Authors:  Helen S Te; Lucas Campbell; Saima Chohan
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-06

Review 2.  Molecular profiling in sarcoidosis.

Authors:  Nicholas K Arger; Brian O'Connor; Laura L Koth
Journal:  Curr Opin Pulm Med       Date:  2020-09       Impact factor: 3.155

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.